2015
DOI: 10.1111/vec.12412
|View full text |Cite
|
Sign up to set email alerts
|

Retrospective cohort study on the incidence of acute kidney injury and death following hydroxyethyl starch (HES 10% 250/0.5/5:1) administration in dogs (2007–2010)

Abstract: HES therapy is associated with increased risk of an adverse outcome including death or AKI in dogs. A randomized controlled trial investigating the safety of HES therapy in canine patients is warranted.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

3
69
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 78 publications
(72 citation statements)
references
References 22 publications
3
69
0
Order By: Relevance
“…In human studies and in 1 canine study, a dose‐response relationship of HES administration has been proposed . The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicine Agency therefore recommends using HES solutions at the lowest effective dose, generally for a maximum of 24 hours and avoiding administration as a constant rate infusion (CRI).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…In human studies and in 1 canine study, a dose‐response relationship of HES administration has been proposed . The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicine Agency therefore recommends using HES solutions at the lowest effective dose, generally for a maximum of 24 hours and avoiding administration as a constant rate infusion (CRI).…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, in an in vitro model of human proximal tubular cells, it was concluded that not the type or size of the HES molecule but rather the number of molecules or cumulative dose was responsible for proximal tubular cell harm . In dogs, the type of HES might influence renal injury, as administration of 10% HES 250/0.5 leads to an increase in AKI while 6% HES 130/0.4 did not . The 2 available studies in cats examined the same tetrastarch; therefore, conclusions regarding the type (pentastarch versus tetrastarch) or concentration (10% versus 6%) remain unanswered.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Hetastarch has the potential to cause acute kidney injury, thought to be due to the accumulation of lysosomes in the proximal tubule from pinocytosis of the colloid particles, leading to tubular swelling and interstitial inflammation (Hayes et al . ). Synthetic colloid use contributes to coagulopathy through decreased levels of von Willebrand factor (vWF) and Factor VIII (fVIII) and decreased expression/activation of platelet integrin α IIb β 3 (Smart et al .…”
Section: Therapeutic Targetsmentioning
confidence: 99%
“…Potential adverse effects of these fluids include dilutional coagulopathy, volume overload and possible colloid-induced kidney injury (Hayes and others 2016). Other injuries induced by the trauma, such as pulmonary contusions or pre-existing comorbidities (eg, cardiac disease), may mean a less aggressive fluid approach is indicated, and if traumatic brain injury is present the use of hypertonic saline may be indicated.…”
mentioning
confidence: 99%